Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma.

Authors:
A Murakami
A Murakami
Osaka University Graduate School of Dentistry
Japan
L Wang
L Wang
National Pingtung University of Science and Technology
Taiwan

Oncogenesis 2017 Jan 16;6(1):e287. Epub 2017 Jan 16.

Molecular Biology Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

A subset of clear cell renal cell carcinoma (ccRCC) tumors exhibit a HIF1A gene mutation, yielding two ccRCC tumor types, H1H2 type expressing both HIF1α and HIF2α, and H2 type expressing HIF2α, but not functional HIF1α protein. However, it is unclear how the H1H2 type ccRCC tumors escape HIF1's tumor-suppressive activity. The polybromo-1 (PBRM1) gene coding for the BAF180 protein, a component of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex, is inactivated in 40% ccRCCs, the function and mechanism of BAF180 mutation is unknown. Our previous study indicates that BAF180-containing SWI/SNF chromatin remodeling complex is a co-activator for transcription factor HIF to induce HIF target genes. Thus, our questions are if BAF180 is involved in HIF-mediated hypoxia response and if PBRM1/BAF180 mutation has any association with the HIF1A retention in H1H2 type ccRCC. We report here that BAF180 is mutated in H1H2 ccRCC cell lines and tumors, and BAF180 re-expression in H1H2 ccRCC cell lines reduced cell proliferation/survival, indicating that BAF180 has tumor-suppressive role in these cells. However, BAF180 is expressed in HIF1-deficient H2 ccRCC cell lines and tumors, and BAF180 knockdown in H2 type ccRCC cell lines reduced cell proliferation/survival, indicating that BAF180 has tumor-promoting activity in these cells. In addition, our data show that BAF180 functions as co-activator for HIF1- and HIF2-mediated transcriptional response, and BAF180's tumor-suppressive and -promoting activity in ccRCC cell lines depends on co-expression of HIF1 and HIF2, respectively. Thus, our studies reveal that BAF180 function in ccRCC is context dependent, and that mutation of PBRM1/BAF180 serves as an alternative strategy for ccRCC tumors to reduce HIF1 tumor-suppressive activity in H1H2 ccRCC tumors. Our studies define distinct functional subgroups of ccRCCs based on expression of BAF180, and suggest that BAF180 inhibition may be a novel therapeutic target for patients with H2, but not H1H2, ccRCC tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1038/oncsis.2016.89DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294252PMC
January 2017
20 Reads

Publication Analysis

Top Keywords

cell lines
20
ccrcc tumors
20
ccrcc cell
20
h1h2 ccrcc
16
baf180
13
ccrcc
13
type ccrcc
12
h1h2 type
12
chromatin remodeling
12
cell
11
cell proliferation/survival
8
proliferation/survival indicating
8
reduced cell
8
type expressing
8
lines tumors
8
remodeling complex
8
swi/snf chromatin
8
tumor-suppressive activity
8
tumors baf180
8
lines reduced
8

References

(Supplied by CrossRef)
Article in CA Cancer J Clin
RL Siegel et al.
CA Cancer J Clin 2016
Article in Cancer Biomark
P Cairns et al.
Cancer Biomark 2010
Article in Kidney Int
RH Weiss et al.
Kidney Int 2006
Article in Clin Cancer Res
WG Kaelin Jr et al.
Clin Cancer Res 2007
Article in Mol Cancer Res
E Jonasch et al.
Mol Cancer Res 2012
Article in Expert Opin Pharmacother
C Porta et al.
Expert Opin Pharmacother 2016
Article in Nature
I Varela et al.
Nature 2011
Article in Hum Mut
G Duns et al.
Hum Mut 2012
Article in N Engl J Med
M Gerlinger et al.
N Engl J Med 2012
Article in Nature
Cancer Genome Atlas Research N. et al.
Nature 2013
Article in Nat Genet
Y Sato et al.
Nat Genet 2013

Similar Publications